Skip to main content

Table 1 Demographic and clinical characteristics of the study patients with genotype-4 chronic hepatitis C

From: Quantitative MDCT and MRI assessment of hepatic steatosis in genotype 4 chronic hepatitis C patients with fibrosis

Variables Number of patients = 115
Age (years, mean ± SD & range) 43.2 ± 12.9 (21–62)
Sex (male/female) 119/36 (76.8/23.2%)
BMI (kg/m2, mean ± SD) 25.6 ± 2.9
Average weight (BMI < 25) 68 (43.9%)
Overweight (BMI 25–30) 87 (56.1%)
Obese (BMI > 30) 0
Serum albumin (g/dL, mean ± SD) 3.8 ± 0.7
Serum bilirubin (mg/dL, median & range) 1.4 (0.6–5.8)
ALT (U/L, mean ± SD) 41.5 ± 20.3
AST (U/L, mean ± SD) 38.9 ± 18.3
ALP (U/L, mean ± SD) 119.4 ± 48.7
Platelet count (103/µL, U/L, mean ± SD) 201.7 ± 72.2
HCV RNA (IU/mL, median & range) 4.5 × 105 (9 × 103–8 × 106)
Histopathological data  
Fibrosis stage (F1/F2/F3/F4) 54/62/13/26 (34.8/40/8.4/16.8)
Hepatitis grades (G1/G2/G3) 68/58/29 (43.9/37.4/18.7)
Steatosis (no/mild/moderate/severe) 23/44/44/21 (29.7/28.4/28.4/13.5)
MDCT data  
CT ratio (mean ± SD, range) 1.1 ± 0.2 (0.3–1.4)
MRI data  
T1-fat fraction (median & range) − 13.5 (− 32.5 to 30.4)
Fat percentage (median & range) 4.8 (− 5.2 to 33.4)
T2 fat suppression (median & range) 0.1 (− 22.5 to 22.2)
Proton density fat fraction% (PDFF) (median & range) 6.2 (0.6–35.2)
ADC for hepatic fibrosis (× 10−3 mm2/s) (median & range) 1.2 (0.97–1.4)
  1. ADC apparent diffusion coefficient, ALT alanine aminotransferase, ALP alkaline phosphatase, AST aspartate aminotransferase, BMI body mass index, SD standard deviation, MDCT multidetector computed tomography, MRI magnetic resonance imaging